Shandong Sinobioway Biomedicine Co., Ltd.
002581.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥2,438 | CN¥9,633 | CN¥10,391 | CN¥14,085 |
| - Cash | CN¥506 | CN¥152 | CN¥184 | CN¥188 |
| + Debt | CN¥3 | CN¥15 | CN¥165 | CN¥177 |
| Enterprise Value | CN¥1,934 | CN¥9,495 | CN¥10,372 | CN¥14,075 |
| Revenue | CN¥360 | CN¥430 | CN¥357 | CN¥403 |
| % Growth | -16.1% | 20.4% | -11.3% | – |
| Gross Profit | CN¥288 | CN¥337 | CN¥281 | CN¥317 |
| % Margin | 79.8% | 78.3% | 78.7% | 78.7% |
| EBITDA | -CN¥104 | -CN¥234 | -CN¥111 | -CN¥144 |
| % Margin | -28.9% | -54.4% | -31% | -35.9% |
| Net Income | -CN¥137 | -CN¥332 | -CN¥15 | CN¥271 |
| % Margin | -38.1% | -77.4% | -4.1% | 67.3% |
| EPS Diluted | -0.6 | -0.5 | -0.022 | 0.41 |
| % Growth | -20% | -2,142.2% | -105.4% | – |
| Operating Cash Flow | -CN¥7 | -CN¥37 | -CN¥54 | -CN¥46 |
| Capital Expenditures | -CN¥9 | -CN¥4 | -CN¥31 | -CN¥61 |
| Free Cash Flow | -CN¥16 | -CN¥41 | -CN¥86 | -CN¥107 |